Literature DB >> 22684210

[Clinical issues with uremia].

M Girndt1.   

Abstract

Uremia describes the consequences of intoxication in chronic renal failure with substances that are renally cleared in healthy individuals. Acute uremia is a syndrome of gastrointestinal symptoms, pericarditis, pleuritis, and central nervous system alterations ending with coma. These symptoms can be resolved by renal replacement therapy. In addition, chronic uremia can result in damage of multiple organ systems, which continues to advance despite dialysis therapy. This is caused by retention of toxins that cannot be adequately removed due to insufficient treatment time or a molecular weight range hampering elimination. Uremic toxins can be generated by the energy or nucleic acid metabolism, they can be proteins or large molecules that are altered chemically by the uremic milieu. Chronic uremia can influence the majority of long-term complications of chronic renal failure: systemic microinflammation, cardiovascular disease, immunodeficiency, malnutrition, anemia, bone metabolism, and polyneuropathy. There are few therapeutic options other than kidney transplantation.

Entities:  

Mesh:

Year:  2012        PMID: 22684210     DOI: 10.1007/s00108-011-3013-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  22 in total

Review 1.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

2.  Indoxyl sulfate, a representative uremic toxin, suppresses erythropoietin production in a HIF-dependent manner.

Authors:  Chih-Kang Chiang; Tetsuhiro Tanaka; Reiko Inagi; Toshiro Fujita; Masaomi Nangaku
Journal:  Lab Invest       Date:  2011-08-22       Impact factor: 5.662

3.  Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect.

Authors:  M Girndt; M Sester; U Sester; H Kaul; H Köhler
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

Review 4.  What we know about oxidative stress in patients with chronic kidney disease on dialysis--clinical effects, potential treatment, and prevention.

Authors:  Lucia Del Vecchio; Francesco Locatelli; Marina Carini
Journal:  Semin Dial       Date:  2011-02-07       Impact factor: 3.455

5.  Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease.

Authors:  J T Kielstein; R H Böger; S M Bode-Böger; J Schäffer; M Barbey; K M Koch; J C Frölich
Journal:  J Am Soc Nephrol       Date:  1999-03       Impact factor: 10.121

6.  Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events.

Authors:  Matthias Girndt; Harald Kaul; Urban Sester; Christof Ulrich; Martina Sester; Thomas Georg; Hans Köhler
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

7.  Inflammation enhances cardiovascular risk and mortality in hemodialysis patients.

Authors:  J Zimmermann; S Herrlinger; A Pruy; T Metzger; C Wanner
Journal:  Kidney Int       Date:  1999-02       Impact factor: 10.612

8.  Effect of membrane permeability on survival of hemodialysis patients.

Authors:  Francesco Locatelli; Alejandro Martin-Malo; Thierry Hannedouche; Alfredo Loureiro; Menelaos Papadimitriou; Volker Wizemann; Stefan H Jacobson; Stanislaw Czekalski; Claudio Ronco; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2008-12-17       Impact factor: 10.121

9.  Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study.

Authors:  J Craig Longenecker; Josef Coresh; Neil R Powe; Andrew S Levey; Nancy E Fink; Alice Martin; Michael J Klag
Journal:  J Am Soc Nephrol       Date:  2002-07       Impact factor: 10.121

10.  Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior.

Authors:  Cedric Auffray; Darin Fogg; Meriem Garfa; Gaelle Elain; Olivier Join-Lambert; Samer Kayal; Sabine Sarnacki; Ana Cumano; Gregoire Lauvau; Frederic Geissmann
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

View more
  1 in total

1.  Pathophysiological aspects of posterior reversible encephalopathy syndrome in two peritoneal-dialyzed children.

Authors:  Tamara Keller; David-Alexander Wille; Guido F Laube
Journal:  Clin Case Rep       Date:  2020-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.